SPY304.32+1.35 0.45%
DIA254.29-0.06 -0.02%
IXIC9,489.87+120.88 1.29%

Vanda Pharmaceuticals Announces Agreement With FDA On Resubmission Of Application For HETLIOZ For The Treatment Of Patients With Smith-Magenis Syndrome

Benzinga · 05/13/2020 11:02